TLSI (TriSalus Life Sciences) Other Gross PPE: $2.64 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TLSI TriSalus Life Sciences Inc TLSI
22 GF Score
Price $5.48
GF Value $3.77
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is TriSalus Life Sciences Other Gross PPE?

TriSalus Life Sciences TLSI +1.67% 22 Other Gross PPE is $2.64 Mil as of Jun. 2026. GuruFocus rates TLSI with a GF Score™ of 22/100 and a GF Value™ of $3.77 (Significantly Overvalued). The stock has 6 warning signs investors should review.

TriSalus Life Sciences's Other Gross PPE for the quarter that ended in Jun. 2026 was $2.64 Mil.

TriSalus Life Sciences's quarterly Other Gross PPE increased from Dec. 2025 ($2.45 Mil) to Mar. 2026 ($2.77 Mil) but then declined from Mar. 2026 ($2.77 Mil) to Jun. 2026 ($2.64 Mil).

TriSalus Life Sciences's annual Other Gross PPE increased from Dec. 2023 ($1.96 Mil) to Dec. 2024 ($2.00 Mil) and increased from Dec. 2024 ($2.00 Mil) to Dec. 2025 ($2.45 Mil).

TriSalus Life Sciences Other Gross PPE Historical Data

* Premium members only.

The historical data trend for TriSalus Life Sciences's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TriSalus Life Sciences Other Gross PPE Chart

TriSalus Life Sciences Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Other Gross PPE
0.80 2.17 1.96 2.00 2.45

TriSalus Life Sciences Quarterly Data
Dec21 Mar22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.81 2.72 2.45 2.77 2.64
TLSI
22GF Score
TriSalus Life Sciences Inc TLSI
Other Gross PPE is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

TriSalus Life Sciences Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.

Frequently Asked Questions Learn more about Other Gross PPE →
What does a Other Gross PPE of $2.64 Mil mean?
TriSalus Life Sciences (TLSI) has a Other Gross PPE of $2.64 Mil as of Jun. 2026. Other Gross PPE is property, plant and equipment recorded on a company's balance sheet that not otherwise classified. View historical data on TriSalus Life Sciences and its competitors.
Is TriSalus Life Sciences' Other Gross PPE too high?
TriSalus Life Sciences' current Other Gross PPE is $2.64 Mil. Overall, TriSalus Life Sciences has a GF Score™ of 22/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does TriSalus Life Sciences' Other Gross PPE compare to TMCI and SENS?
TriSalus Life Sciences' Other Gross PPE of $2.64 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Gross PPE for a Medical Devices & Instruments company?
A good Other Gross PPE depends on the Medical Devices & Instruments industry context. However, Other Gross PPE should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Gross PPE mean?
A high Other Gross PPE can signal that a stock is expensive relative to its fundamentals. Other Gross PPE is property, plant and equipment recorded on a company's balance sheet that not otherwise classified. View historical data on TriSalus Life Sciences and its competitors. TriSalus Life Sciences's current Other Gross PPE is $2.64 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TriSalus Life Sciences stock overvalued right now?
Based on GuruFocus' analysis, TriSalus Life Sciences (TLSI) is currently considered Significantly Overvalued. The stock's GF Value™ is $3.77, compared to a current price of $5.48 — trading 45.4% above its estimated fair value. The current Other Gross PPE is $2.64 Mil. TriSalus Life Sciences' overall GF Score™ is 22/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Gross PPE calculated?
Other Gross PPE is calculated from a company's financial statements. For TriSalus Life Sciences (TLSI), the current Other Gross PPE is $2.64 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is TriSalus Life Sciences (TLSI) Overvalued in 2026?

Based on GuruFocus' analysis, TriSalus Life Sciences stock appears to be overvalued. The current stock price of $5.48 is trading 45.4% above its estimated GF Value™ of $3.77. GuruFocus considers TriSalus Life Sciences to be Significantly Overvalued.

Key valuation signals for TLSI:

  • Other Gross PPE: $2.64 Mil
  • GF Value™: $3.77 vs. price of $5.48 (45.4% above fair value)
  • GF Score™: 22/100 with 6 warning signs

No single metric tells the full story. See the TLSI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

TriSalus Life Sciences Business Description

Address 6272 W. 91st Avenue, Westminster, CO, USA, 80031
TriSalus Life Sciences Inc is an oncology-focused medical technology business integrating its delivery technology with standard-of-care therapies and its investigational immunotherapeutic, nelitolimod, a class C Toll-like receptor 9 (TRL9) agonist, for patients with solid tumors. The company developed Pressure-Enabled Drug Delivery (PEDD) to overcome high intratumoral pressure and off-target delivery. Its 510(k) cleared device, the TriNav Infusion System using PEDD technology, is used for interventional radiology procedures including transarterial radioembolization (TARE) and transarterial chemoembolization (TACE) in patients with primary liver cancer or liver metastases. It has one reportable segment and generates revenue from sales of PEDD infusion systems, principally related to TriNav.
22GF Score

Get the complete analysis for TLSI

Other Gross PPE is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.48
Price
$3.77
GF Value